Prof. David Araújo-Vilar, University of Santiago de Compostela, Spain
Prof. David Araujo Vilar has received honorary as board member, steering committee member, and/or speaker to Amryt Pharma, Regeneron, and Third Rock Ventures.
Prof. Ferrucio Santini has worked as a consultant, participated in studies, and/or received travel funds from the following companies,
which are involved with lipodystrophy and/or diabetes: AstraZeneca, Aegerion/Amryt, Novo Nordisk.
Dr. Akinci is a compensated consultant for Amryt Pharmaceuticals. Dr. Akinci serves as a consultant, add board member, steering committee member, and/or speaker to Regeneron, Third Rock Ventures, AstraZeneca, Novonordisk, Boehringer Ingelheim, Sanofi, Novartis, Bilim Ilac, ARIS, and Servier.